Personalized risk messages may not increase colorectal cancer screening uptake
1. In this randomized controlled trial, using personalized risk messages and provider notifications did not significantly increase screening uptake overall. ...
1. In this randomized controlled trial, using personalized risk messages and provider notifications did not significantly increase screening uptake overall. ...
AI Blood Test Could Replace Colonoscopies Forget the prep kits and uncomfortable procedures—there’s a new blood test that might change ...
Click here to read this study in the Lancet. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be ...
1. In this randomized controlled trial, participants with an abnormal fecal immunochemical test who received patient navigation had higher rates ...
1. In this updated systematic review and meta-analysis, computer-aided detection found more polyps and adenomas per colonoscopy compared with standard ...
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
1. In this prospective cohort study, the adenoma detection rate (ADR) was inversely associated with colorectal cancer (CRC) risk in ...
1. In this randomized controlled trial, cold snare polypectomy (CSP) reduced the risk of delayed post-polypectomy bleeding compared to hot ...
1. Use of video capsule endoscopy was associated with increased detection of bleeding and reduced use of personal protective equipment ...
1. In this microsimulation model of U.S. patients aged 50-79, high-intensity surveillance following colorectal adenoma provided clinically significant benefits over ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.